PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
Inhibition of WEE1 kinase by AZD1775 has shown promising results in clinical cancer trials, but markers predicting AZD1775 response are lacking. Here we analysed AZD1775 response in a panel of human breast cancer (BC) cell lines by global proteome/transcriptome profiling and identified two groups of...
Main Authors: | Andrä Brunner, Aldwin Suryo Rahmanto, Henrik Johansson, Marcela Franco, Johanna Viiliäinen, Mohiuddin Gazi, Oliver Frings, Erik Fredlund, Charles Spruck, Janne Lehtiö, Juha K Rantala, Lars-Gunnar Larsson, Olle Sangfelt |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2020-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/57894 |
Similar Items
-
Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant Phenotypes of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
by: Shuning Bi, et al.
Published: (2019-08-01) -
Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations
by: Xiangbing Meng, et al.
Published: (2021-10-01) -
Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the <i>dl922-947</i> Oncolytic Virus in Malignant Mesothelioma Cell Lines
by: Carmelina Antonella Iannuzzi, et al.
Published: (2020-10-01) -
Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
by: Tamara B. Garcia, et al.
Published: (2020-03-01) -
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage
by: Mathilde Rikje Willemijn de Jong, et al.
Published: (2019-11-01)